Fundraising Fox
Octozi
4 known investors
Find your way into Octozi
Sign up to see every warm intro you have to Octozi
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Octozi team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Octozi provides AI-powered automation for clinical data workflows including cleaning, review, reconciliation, reporting, and operations in clinical trials. The platform serves pharmaceutical sponsors and clinical development teams seeking to reduce manual data handling and errors.
Founders & leadership
Investors · 4
How we know: Debiopharm Innovation Fund's portfolio page · the company's own site · funding news · Not right? Tell us
How we know: the VCSheet dataset · Not right? Tell us
How we know: a partner's Signal profile · alleywatch.com · funding news · Not right? Tell us
Funding
SEC filings, press & company announcements$3M disclosed across 1 round · 2026
- $3MSeedJul 2026 · 2 sources
Surface Ventures (lead), Remarkable Ventures
Source ↗
Source: company announcements and press reports — follow each round's link for the claim.
In the news
Frequently asked questions
- What does Octozi do?
- Octozi provides AI-powered automation for clinical data workflows including cleaning, review, reconciliation, reporting, and operations in clinical trials. The platform serves pharmaceutical sponsors and clinical development teams seeking to reduce manual data handling and errors.
- Who founded Octozi?
- Octozi was founded by Amit Patel, Matt Purri, PhD.
- Who are Octozi's investors?
- Octozi's investors include Debiopharm Innovation Fund, Entrepreneurs Roundtable Accelerator (ERA), Remarkable Ventures, Surface Ventures.
- How much funding has Octozi raised?
- Octozi has disclosed $3M raised across 1 round.